Cellular Immune Responses Induced with Dose-Sparing Intradermal Administration of HIV Vaccine to HIV-Uninfected Volunteers in the ANRS VAC16 Trial

Odile Launay, Christine Durier, Corinne Desaint et al. · 2007

Read Cellular Immune Responses Induced with Dose-Sparing Intradermal Administration of HIV Vaccine to HIV-Uninfected Volunteers in the ANRS VAC16 Trial by Odile Launay, Christine Durier, Corinne Desaint et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0000725.txt.

Description

Odile Launay, Christine Durier, Corinne Desaint and colleagues compared two routes for delivering an HIV vaccine in the ANRS VAC16 trial. Their 2007 PLOS ONE objective was safety and cellular immune response. Healthy, HIV-uninfected volunteers received a candidate vaccine called LIPO-4, built from HIV lipopeptides. One group got it intradermally, into the skin; the other intramuscularly, into muscle.

The trial was randomized and open-label, run in France at six sites with 24 weeks of follow-up. Intradermal delivery is dose-sparing, stretching limited vaccine further. If skin delivery with less vaccine matches muscle delivery, vaccination campaigns gain reach. Cellular responses, T cell reactions, were the measure that mattered here.

Catalog record

CREATOROdile Launay, Christine Durier, Corinne Desaint et al.
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000725

Browse the full library · About the Tower of Babel